Low-dose post-transplant cyclophosphamide and anti-thymocyte globulin as an effective strategy for GVHD prevention in haploidentical patients

Posttransplantation cyclophosphamide prevents graft-versus-host disease by inducing alloreactive T cell dysfunction and suppression

(2019) Lucas P. Wachsmuth et al.   JOURNAL OF CLINICAL INVESTIGATION

Early Cytomegalovirus Reactivation and Expansion of CD56brightCD16dim/−DNAM1+ Natural Killer Cells Are Associated with Antileukemia Effect after Haploidentical Stem Cell Transplantation in Acute Leukemia

(2019) Ji Eun Jang et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

NK cell reconstitution following unmanipulated HLA-mismatched/haploidentical transplantation compared with matched sibling transplantation

(2019) Li-Juan Hu et al.   Science China-Life Sciences

Sequential Conditioning with Thiotepa in T Cell- Replete Hematopoietic Stem Cell Transplantation for the Treatment of Refractory Hematologic Malignancies: Comparison with Matched Related, Haplo-Mismatched, and Unrelated Donors

(2018) Rémy Duléry et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

The consensus on indications, conditioning regimen, and donor selection of allogeneic hematopoietic cell transplantation for hematological diseases in China—recommendations from the Chinese Society of Hematology

(2018) Lanping Xu et al.   Journal of Hematology & Oncology

Reduced-Intensity Conditioning and Dual T Lymphocyte Suppression with Antithymocyte Globulin and Post-Transplant Cyclophosphamide as Graft-versus-Host Disease Prophylaxis in Haploidentical Hematopoietic Stem Cell Transplants for Hematological Malignancies

(2018) Arjun Datt Law et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

The consensus on the monitoring, treatment, and prevention of leukemia relapse after allogeneic hematopoietic stem cell transplantation in China

(2018) Yu Wang et al.   CANCER LETTERS

The role of collateral related donors in haploidentical hematopoietic stem cell transplantation

(2018) Xiao-Dong Mo et al.   Science Bulletin

Low-dose anti-thymocyte globulin plus low-dose posttransplant cyclophosphamide as graft-versus-host disease prophylaxis in haploidentical peripheral blood stem cell transplantation combined with unrelated cord blood for patients with hematologic malignancies: a prospective, phase II study

(2018) Jun Yang et al.   BONE MARROW TRANSPLANTATION

Low-dose post-transplant cyclophosphamide can mitigate GVHD and enhance the G-CSF/ATG induced GVHD protective activity and improve haploidentical transplant outcomes

(2017) Yu Wang et al.   OncoImmunology

Haploidentical Hematopoietic Stem Cell Transplantation: A Global Overview Comparing Asia, the European Union, and the United States

(2016) Jane Apperley et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Haploidentical versus Matched-Sibling Transplant in Adults with Philadelphia-Negative High-Risk Acute Lymphoblastic Leukemia: A Biologically Phase III Randomized Study

(2016) Y. Wang et al.   CLINICAL CANCER RESEARCH

Impact of conditioning intensity in T-replete haplo-identical stem cell transplantation for acute leukemia: a report from the acute leukemia working party of the EBMT

(2016) Marie T. Rubio et al.   Journal of Hematology & Oncology

Minimal residual disease- and graft-vs.-host disease-guided multiple consolidation chemotherapy and donor lymphocyte infusion prevent second acute leukemia relapse after allotransplant

(2016) Chen-Hua Yan et al.   Journal of Hematology & Oncology

Haploidentical transplant for myelodysplastic syndrome: registry-based comparison with identical sibling transplant

(2016) Y Wang et al.   LEUKEMIA

Haploidentical bone marrow and stem cell transplantation: experience with post-transplantation cyclophosphamide

(2016) Tara M. Robinson et al.   SEMINARS IN HEMATOLOGY

Measuring Therapeutic Response in Chronic Graft-versus-Host Disease. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: IV. The 2014 Response Criteria Working Group Report

(2015) Stephanie J. Lee et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia

(2015) S. O. Ciurea et al.   BLOOD

Haploidentical vs identical-sibling transplant for AML in remission: a multicenter, prospective study

(2015) Yu Wang et al.   BLOOD

Outcomes of Nonmyeloablative HLA-Haploidentical Blood or Marrow Transplantation With High-Dose Post-Transplantation Cyclophosphamide in Older Adults

(2015) Yvette L. Kasamon et al.   JOURNAL OF CLINICAL ONCOLOGY

Donor-specific anti-human leukocyte antigen antibodies were associated with primary graft failure after unmanipulated haploidentical blood and marrow transplantation: a prospective study with randomly assigned training and validation sets

(2015) Ying-Jun Chang et al.   Journal of Hematology & Oncology

Who is the best donor for a related HLA haplotype-mismatched transplant?

(2014) Y. Wang et al.   BLOOD

HLA-haploidentical hematopoietic SCT from collateral related donors without in vitro T-cell depletion for hematological malignancies

(2014) Y-y Zhang et al.   BONE MARROW TRANSPLANTATION

Absence of Post-Transplantation Lymphoproliferative Disorder after Allogeneic Blood or Marrow Transplantation Using Post-Transplantation Cyclophosphamide as Graft-versus-Host Disease Prophylaxis

(2013) Jennifer A. Kanakry et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Influence of two different doses of antithymocyte globulin in patients with standard-risk disease following haploidentical transplantation: a randomized trial

(2013) Y Wang et al.   BONE MARROW TRANSPLANTATION

T-Cell–Replete HLA-Haploidentical Hematopoietic Transplantation for Hematologic Malignancies Using Post-Transplantation Cyclophosphamide Results in Outcomes Equivalent to Those of Contemporaneous HLA-Matched Related and Unrelated Donor Transplantation

(2013) Asad Bashey et al.   JOURNAL OF CLINICAL ONCOLOGY

HLA-haploidentical bone marrow transplantation with posttransplant cyclophosphamide expands the donor pool for patients with sickle cell disease

(2012) J. Bolanos-Meade et al.   BLOOD

A disease risk index for patients undergoing allogeneic stem cell transplantation

(2012) P. Armand et al.   BLOOD